PharmaVoice - Latest News for pharmacy prosen-usFri, 14 Jun 2024 08:00:00 -0400Pfizer’s Paxlovid flunks long COVID study as researchers uncover the condition’s deep toll<p>While researchers gain ground understanding long COVID&rsquo;s impact, viable treatments could still be a long way off.</p>Meagan ParrishFri, 14 Jun 2024 08:00:00 -0400 CEO to step down after 15 years<p>Kenneth Mills will become chair of the gene therapy developer&#39;s board while Curran Simpson, the current chief operating officer, will take his place as company head.</p>Ned PagliaruloThu, 13 Jun 2024 12:00:00 -0400’s adcomm win shows amyloid and tau will likely dominate Alzheimer’s — for now<p>Lilly is the latest to approach the coveted Alzheimer&rsquo;s approval, but a slate of drugmakers are lining up clinical trials in amyloid and tau to take a shot at improving patient outcomes.</p>Michael GibneyThu, 13 Jun 2024 08:00:00 -0400 the powerful computations, AI’s role in pharma is still beset by challenges<p>Small biotechs are saving time and money leveraging AI to develop new drugs, but incomplete data and disease complexity remain hurdles for the space.</p>Amy BaxterWed, 12 Jun 2024 08:00:00 -0400 adcomm rejection, Lykos CEO sees future for MDMA drug<p>Although the rebuff makes approval &ldquo;a bit more challenging,&rdquo; Lykos is moving forward with the psychedelic-based treatment for PTSD.</p>Alexandra PecciWed, 12 Jun 2024 08:00:00 -0400’s platform designation aims to ease R&D pain points<p>A new program creates approval pathways for multiple drugs developed on the same platform.&nbsp;</p>Amy BaxterTue, 11 Jun 2024 08:00:00 -0400 Big Pharma places bigger bets on ADCs, here’s where the field is headed next<p>With more drugmakers getting into the antibody-drug conjugate game, emerging innovations signal a bright future for the technology.</p>Michael GibneyTue, 11 Jun 2024 08:00:00 -0400 Big Pharma’s layoffs — is there an end in sight?<p>A slew of major companies, including BMS, have announced cost-cutting measures in recent months. What will it take to turn the tide?</p>Kelly BilodeauMon, 10 Jun 2024 08:00:00 -0400’s R&D gamble: picking pipeline winners in a risky field<p>How leaders from biotech, Big Pharma and the investment world know when they&#39;ve found the right candidate or company to back.</p>Meagan ParrishFri, 07 Jun 2024 08:00:00 -0400 ‘widening gap’ in access to new cancer meds drives efforts from City of Hope and Bristol Myers<p>Cancer care is improving so quickly that receiving newer medications can be difficult &mdash; City of Hope&rsquo;s wide oncology network and a 10-year commitment from Bristol Myers Squibb offer some solutions.</p>Michael GibneyThu, 06 Jun 2024 08:00:00 -0400